Female Infertility Due to Diminished Ovarian Reserve Clinical Trial
Official title:
Does the Addition of Growth Hormone to the Invitro Fertilization/ Intracytoplasmic Sperm Injection Antagonist Protocol Improve Outcome in Poor Responders? A Randomized Controlled Trial
The effect of use of the growth hormone with antagonist protocol on the outcome of the IVF/ICSI cycles in poor responders.
Two groups of poor responder female patients planned to receive the antagonist IVF/ICSI protocol are randomized to whether or not to add growth hormone to their protocol. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01915186 -
Use of Dehydroepiandrosterone (DHEA) in Women With Normal and Poor Ovarian Reserve Undergoing IVF
|
N/A | |
Withdrawn |
NCT02209168 -
Differences in Ovarian Reserve Markers and Vitamin D Between Infertile Indian, Arabian and Caucasian Population
|
||
Completed |
NCT02341365 -
Vitamin D Influence on Oocyte Donation
|
N/A | |
Completed |
NCT02185326 -
Microflare Protocol in Poor Responders
|
Phase 4 | |
Completed |
NCT01897324 -
IVF/ICSI Protocols in Poor Responders With Growth Hormone
|
Phase 4 | |
Recruiting |
NCT02294500 -
Cohort Study to Evaluate Ovarian Function
|
N/A | |
Recruiting |
NCT01662466 -
Effect of Testosterone Treatment on Embryo Quality
|
Phase 1/Phase 2 | |
Enrolling by invitation |
NCT02179255 -
Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF
|
Phase 1/Phase 2 |